ENALAPRIL - A NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR

被引：26

作者：

CLEARY, JD

TAYLOR, JW

机构：

[1] UNIV MISSISSIPPI, DEPT CLIN PHARM PRACTICE, 2500 N STATE ST, JACKSON, MS 39216 USA

[2] UNIV MINNESOTA, COLL PHARM, MINNEAPOLIS, MN 55455 USA

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1986年 / 20卷 / 03期

关键词：

D O I：

10.1177/106002808602000301

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：177 / 186

页数：10

共 103 条

[1]

Abrams WB, 1984, J HYPERTENS S2, V2, P31

[2]

AMABILE G, 1984, J HYPERTENS, V2, P427

[3]

ANDREN L, 1983, J HYPERTENS S2, V1, P384

[4]

[Anonymous], 1984, Br J Clin Pharmacol, V18, P51

[5]

BARNES JN, 1983, LANCET, V2, P41

[6] COMPARATIVE STUDIES - ENALAPRIL VERSUS HYDROCHLOROTHIAZIDE AS 1ST-STEP THERAPY FOR THE TREATMENT OF PRIMARY HYPERTENSION [J].

BAUER, JH ;

JONES, LB .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1984, 4 (01) :55-62

[7]

BERGSTRAND R, 1982, BRIT J CLIN PHARMACO, V14, pP136

[8] ANTIHYPERTENSIVE THERAPY WITH MK-421 - ANGIOTENSIN-II-RENIN RELATIONSHIPS TO EVALUATE EFFICACY OF CONVERTING ENZYME BLOCKADE [J].

BIOLLAZ, J ;

BRUNNER, HR ;

GAVRAS, I ;

WAEBER, B ;

GAVRAS, H .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) :966-972

[9] ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].

BIOLLAZ, J ;

SCHELLING, JL ;

COMBES, BJD ;

BRUNNER, DB ;

DESPONDS, G ;

BRUNNER, HR ;

ULM, EH ;

HICHENS, M ;

GOMEZ, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368

[10] EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].

BRUNNER, DB ;

DESPONDS, G ;

BIOLLAZ, J ;

KELLER, I ;

FERBER, F ;

GAVRAS, H ;

BRUNNER, HR ;

SCHELLING, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467

← 1 2 3 4 5 6 7 8 9 10 →